Capital Research Global Investors’s Health Catalyst HCAT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-568,785
| Closed | -$6.64M | – | 424 |
|
|
2023
Q1 | $6.64M | Hold |
568,785
| – | – | ﹤0.01% | 403 |
|
|
2022
Q4 | $6.05M | Hold |
568,785
| – | – | ﹤0.01% | 409 |
|
|
2022
Q3 | $5.52M | Hold |
568,785
| – | – | ﹤0.01% | 407 |
|
|
2022
Q2 | $8.24M | Sell |
568,785
-2,823,215
| -83% | -$40.9M | ﹤0.01% | 397 |
|
|
2022
Q1 | $88.6M | Hold |
3,392,000
| – | – | 0.02% | 315 |
|
|
2021
Q4 | $134M | Buy |
3,392,000
+275,700
| +9% | +$10.9M | 0.03% | 289 |
|
|
2021
Q3 | $156M | Buy |
3,116,300
+27,083
| +0.9% | +$1.35M | 0.04% | 268 |
|
|
2021
Q2 | $171M | Buy |
3,089,217
+94,917
| +3% | +$5.27M | 0.04% | 261 |
|
|
2021
Q1 | $140M | Buy |
2,994,300
+111,600
| +4% | +$5.22M | 0.03% | 276 |
|
|
2020
Q4 | $125M | Hold |
2,882,700
| – | – | 0.03% | 274 |
|
|
2020
Q3 | $106M | Buy |
2,882,700
+1,386,500
| +93% | +$50.7M | 0.03% | 267 |
|
|
2020
Q2 | $43.6M | Buy |
1,496,200
+1,300,000
| +663% | +$37.9M | 0.01% | 327 |
|
|
2020
Q1 | $5.13M | Hold |
196,200
| – | – | ﹤0.01% | 373 |
|
|
2019
Q4 | $6.81M | Sell |
196,200
-26,900
| -12% | -$933K | ﹤0.01% | 387 |
|
|
2019
Q3 | $7.06M | Buy |
+223,100
| New | +$7.06M | ﹤0.01% | 391 |
|